Equitrans Midstream Corp Equity Method Investment, Other than Temporary Impairment
Equitrans Midstream Corp reported Equity Method Investment, Other than Temporary Impairment of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-20.
Discontinued › Income Statement › Other Income
us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment · last filed 2024-02-20
- Equitrans Midstream Corp equity method investment, other than temporary impairment for the quarter ending 2023-12-31 was $0.00.
- Equitrans Midstream Corp equity method investment, other than temporary impairment for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- Equitrans Midstream Corp equity method investment, other than temporary impairment for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- Equitrans Midstream Corp equity method investment, other than temporary impairment for the quarter ending 2022-09-30 was $583.06M.
- Equitrans Midstream Corp equity method investment, other than temporary impairment for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Equitrans Midstream Corp equity method investment, other than temporary impairment for fiscal 2022 was $583.06M, a 69.73% decline from fiscal 2021.
- Equitrans Midstream Corp equity method investment, other than temporary impairment for fiscal 2021 was $1.93B.
- Equitrans Midstream Corp equity method investment, other than temporary impairment for fiscal 2020 was $0.00.
| Period end | Equity Method Investment, Other than Temporary Impairment 3 month | Equity Method Investment, Other than Temporary Impairment 6 month | Equity Method Investment, Other than Temporary Impairment 9 month | Equity Method Investment, Other than Temporary Impairment 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $0.00 derived: sum of 2 quarters · filed 2024-02-20 | $0.00 10-K · filed 2024-02-20 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-10-31 | $0.00 10-Q · filed 2023-10-31 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $583.06M derived: sum of 2 quarters · filed 2024-02-20 | $583.06M 10-K · filed 2024-02-20 | |
| 2022-09-30 | $583.06M 10-Q · filed 2023-10-31 | $583.06M 10-Q · filed 2023-10-31 | ||
| 2021-12-31 | $1.93B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $1.93B derived: sum of 2 quarters · filed 2024-02-20 | $1.93B 10-K · filed 2024-02-20 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-02 | $0.00 10-Q · filed 2022-11-02 | ||
| 2020-12-31 | $0.00 10-K · filed 2023-02-21 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-23 |